Second Dissemination Event of the ProCAncer-I Project in Lisbon

Published on: July 6, 2023
Categories: Events | News

A great pleasure to have participated in the “AI and Machine Learning in Cancer Imaging 3.0 – Enhancing Healthcare through AI” event on 30th June & 1st July 2023 in Lisbon, Portugal. The event was organised jointly by the Champalimaud Foundation and the International Cancer Imaging Society.

During the event, we had a special session with the title: The best practices on machine learning for multicentric approacheswhere we discussed and presented the ProCAncer-I project

At the presentation and discussion panel participated members both of the ProCAncer -I project and the EuCanImage project: Nickolas Papanikolaou, Daniele Regge, Karim Lekadir, Maciej Bobowicz, Kostas Marias and Henkjan Huisman

The session was an opportunity for the researchers to engage with different stakeholders as well as the public. It aimed to promote the better understanding and application of AI and machine learning in cancer imaging for radiologists, technicians/ radiographers, scientists and industry partners.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!